Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment

doi:10.12998/wjcc.v10.i32.11690

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6107)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

283

WORD

HTML

4434

Figures (1-3)

289

Tables (1-2)

307

Sum=5348

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

268

Download

490

Sum=758

Nov 16, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Nov 16, 2022; 10(32): 11690-11701
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11690

Full Size Figure Download Figure

Figure 3 Ubiquitin-specific peptidases inhibitors. USPs: Ubiquitin-specific peptidases; 6-TG: 6-thioguanine.

Citation: Huang ML, Shen GT, Li NL. Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World J Clin Cases 2022; 10(32): 11690-11701
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11690.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11690